Journal of the American Academy of Dermatology
Updates in adjuvant and neoadjuvant therapies for resectable cutaneous melanoma.
Matthew J Hadfield, Sonal Muzumdar, Ryan J Sullivan, Steven Katz, Jane M Grant-Kels
Published: 202510.1016/j.jaad.2025.12.068
Abstract
Over the last 15 years, treatment of melanoma has been revolutionized using immune checkpoint inhibitors and mitogen-activated protein kinase-targeted therapies. However, some patients are at high risk of disease recurrence. Therefore, strategies to…
Preview only. Read the full abstract at the source